1st patient recruited in phase 3 study of masitinib in PPMS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

1st patient recruited in phase 3 study of masitinib in PPMS

Postby MSUK » Wed Sep 07, 2011 5:17 am

Image

AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), announced today recruitment of the first patient in the phase 3 study of masitinib in primary progressive multiple sclerosis or relapse free secondary progressive multiple sclerosis.

This is an international, multicenter, randomized, double-blind, placebo-controlled, phase 3 study. Its objective is to compare the efficacy and safety of masitinib at 6 mg/kg/day with placebo in the treatment of patients with primary progressive multiple sclerosis or relapse free secondary progressive multiple sclerosis. This study will enroll approximately 450 patients, across 60 centers around the world, randomized with a ratio of 2:1 between the masitinib and placebo groups. The primary response evaluation will be the proportion of patients to achieve an improvement of at least 100% in their symptoms, as measured by the Multiple Sclerosis Functional Composite (MSFC) score, after 96 weeks of treatment.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/3226
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: 1st patient recruited in phase 3 study of masitinib in P

Postby Daisy3 » Fri Sep 09, 2011 1:36 am

How exciting.
There is something for PPMS patients.
Let's hope they are successful!
User avatar
Daisy3
Family Elder
 
Posts: 308
Joined: Tue Feb 09, 2010 4:00 pm


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service